A pharmacy advertises the COVID-19 vaccine as the nation marks the fifth anniversary of the Covid-19 pandemic on March 13, 2025 in New York City

A pharmacy advertises the COVID-19 vaccine as the nation marks the fifth anniversary of the Covid-19 pandemic on March 13, 2025 in New York City

 SPENCER PLATT

The United States will limit routine Covid-19 boosters to people over 65 or those at higher risk of serious illness, while requiring new placebo-controlled trials to justify vaccines for healthy individuals under that threshold, senior health officials said Tuesday.

In a letter to the prestigious New England Journal of Medicine, the Food and Drug Administration's Vinayak Prasad and Commissioner Martin Makary said the shift brought US policy more in line with European nations.

Originally published on doc.afp.com, part of the BLOX Digital Content Exchange.